首页 | 本学科首页   官方微博 | 高级检索  
   检索      


IDH mutations in glioma and acute myeloid leukemia
Authors:Lenny Dang  Shengfang Jin  Shinsan M Su
Institution:3. From the Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065;5. Human Oncology and Pathogenesis Program, Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10065;6. Melanoma and Sarcoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065;4. the Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104;1. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA;2. Sarah Cannon Research Institute, Nashville, TN, USA;3. Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;4. Department of Medicine, University of Arizona Cancer Center, Tucson, AZ, USA;5. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;6. Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA;7. Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA;8. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA;9. Department of Medicine, University of Colorado Cancer Center, Aurora, CO, USA;10. Department of Drug Development, Institut Gustave Roussy Cancer Centre, Villejuif, France;11. START Center for Cancer Care, San Antonio, TX, USA;12. Department of Medical Oncology, Sylvester Comprehensive Cancer Center, Miami, FL, USA;13. Agios Pharmaceuticals, Inc, Cambridge, MA, USA;14. Department of Medicine, Weill Cornell Medical College, New York, NY;1. Department of Neurosurgery, Shanghai Tenth People''s Hospital, Tongji University School of Medicine, Shanghai 200072, People''s Republic of China;2. Department of Neurosurgery, Affiliated Hospital of Nantong University, 20 Xisi Road, Nantong 226001, Jiangsu Province, People''s Republic of China;3. Department of Pathology, Shanghai Tenth People''s Hospital, Tongji University School of Medicine, Shanghai, People''s Republic of China;1. University of Maryland, School of Medicine, Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD;2. Institute of Medical Science, University of Toronto, Toronto, Canada;3. Brain Science Institute, Johns Hopkins University, Baltimore, MD;4. Department of Hematology and Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA;5. Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Canada;6. Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA;1. Department of Biophysics, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China;2. Institute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China;3. Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing 100191, China;1. Molecular and Cell Biology Lab, Institute of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China;2. Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China;3. Department of Pharmacology and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA;4. Department of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号